Skip to content

Analgesia effect of single intrathecal injection of optimal dose of hydromorphone after gasrectomy

Analgesia effect of single intrathecal injection of optimal dose of hydromorphone after gasrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073827
Enrollment
Unknown
Registered
2023-07-21
Start date
2023-07-21
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgeisa

Interventions

Intrathecal hydromorphone group:Intrathecal 150µg hydromorphone
Transversus abdominis plane block group:Ultrasound-guided abdominal transversus abdominis plane block with 60ml 0.2% ropivacaine dual four-point apporoach

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Adult patients; 2)American Society of Anesthesiologists (ASA) classification I to III; 3) Scheduled to undergo elective partial hepatectomy with general anesthesia.

Exclusion criteria

Exclusion criteria: 1)Patients whose body mass index (BMI)is equal to or less than 18kg/m2 or greater than 30kg/m2; 2)Patients with contraindications for performing intrathecal block, including coagulation dysfunction (platelets 1.5, or current anticoagulant therapy), abnormal vertebral anatomy, previous spinal disease or surgery, puncture site infection, severe chronic back pain or suspected spinal metastases of a malignant tumor ; 3)patients with ?severe comorbidities (renal dysfunction, hepatic impairment, cardiac insufficiency or severe pulmonary disease), expected to be transferred to the ICU after surgery; 4)patients with chronic pain syndrome or current opioid use exceeding 60mg of oral morphine or equivalent per day; 5) patients with allergy to drugs relevant to the study; 6)patients who can not understand the research process, the assessment; and the instructions of PCA pump; 7)patients participation in other clinical trials 3months prior to the present trial are excluded from the trail.

Design outcomes

Primary

MeasureTime frame
Area under the curve(AUC) of pain score over time with movement within 24 hours after surgery;

Secondary

MeasureTime frame
Area under the curve(AUC) of pain score over time at rest within 24 hours after surgery;Area under the curve(AUC) of pain score over time at rest and with movement after surgery ( 48 h, 72 h);Total analgetic uses within 72 h after surgery (24h,48h,72h);Time need to get out of bed after surgery;Overall satisfaction with analgesia;15-item quality of recovery scale;Length of stay in hospital after surgery;

Countries

China

Contacts

Public ContactLi Qian

West China Hospital, Sichuan University

hxliqian@foxmail.com+86 189 8060 1635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 20, 2026